(ONTEX) Ontex - Ratings and Ratios

Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974276082

Baby Diapers, Feminine Care, Adult Incontinence, Wipes

ONTEX EPS (Earnings per Share)

EPS (Earnings per Share) of ONTEX over the last years for every Quarter: "2020-03": 0.25331497467467, "2020-06": 0.50662994934933, "2020-09": 0.079698209446894, "2020-12": 0.15945197961487, "2021-03": 0.044409793839868, "2021-06": 0.088819587679736, "2021-09": -0.42651372250807, "2021-12": -0.85367345199106, "2022-03": -0.61605927008705, "2022-06": -2.1169353593665, "2022-09": -0.30197823533553, "2022-12": -1.2188644225922, "2023-03": 0.012334517035818, "2023-06": -0.23682272708771, "2023-09": 0.15355829726666, "2023-12": 0.66599984460004, "2024-03": 0.059766749477503, "2024-06": 0.059766749477503, "2024-09": 0.099201703558199, "2024-12": 0.19239961759082, "2025-03": 0, "2025-06": -1.4290106590752,

ONTEX Revenue

Revenue of ONTEX over the last years for every Quarter: 2020-03: 526.7, 2020-06: 1053.4, 2020-09: 516.7, 2020-12: 1033.4, 2021-03: 343.45, 2021-06: 980.6, 2021-09: 522.9, 2021-12: 1045.8, 2022-03: 390.3, 2022-06: 780.6, 2022-09: 638.1, 2022-12: -117.7, 2023-03: 445.9, 2023-06: 891.8, 2023-09: 567.9, 2023-12: 902.9, 2024-03: 458.05, 2024-06: 458.05, 2024-09: 472.2, 2024-12: 944.4, 2025-03: null, 2025-06: 880.3,

Description: ONTEX Ontex

Ontex Group NV is a global player in the personal hygiene products market, offering a diverse range of baby, feminine, and adult care products under various brands across multiple regions, including Europe, the Americas, and internationally. The companys product portfolio includes diapers, wipes, sanitary towels, tampons, and adult incontinence products, catering to consumers, retailers, and healthcare providers. With a strong presence in several countries, Ontex has established itself as a significant supplier of personal care products, leveraging its extensive brand portfolio and distribution networks.

Ontexs brand portfolio is a key strength, with a mix of regional and international brands that cater to different market segments. The companys ability to offer products under retailer brands is also a significant advantage, as it allows for greater flexibility and penetration in various markets. With a global footprint, Ontex is well-positioned to capitalize on the growing demand for personal hygiene products, driven by demographic trends and increasing awareness of hygiene and health.

Analyzing the , Ontexs stock is currently trading at €7.11, below its short-term and long-term moving averages, indicating a potential downtrend. The Average True Range (ATR) of 0.16 (2.22%) suggests moderate volatility, and the 52-week high and low range indicates a relatively stable price movement. Based on the technical indicators, a potential trading range for ONTEX could be between €7.01 and €7.50, with a potential breakout above €7.50 or breakdown below €7.01.

From a fundamental perspective, Ontexs indicates a market capitalization of €611.19M, with a P/E ratio of 30.08 and a forward P/E of 6.31, suggesting a relatively high valuation compared to its projected earnings. The Return on Equity (RoE) of 8.67% is relatively modest. Considering the companys growth prospects, driven by the increasing demand for personal hygiene products, and its global footprint, a potential re-rating of the stock could occur if the company is able to demonstrate sustained growth and profitability.

Forecasting the future performance of Ontex, based on the and , we can expect the stock to potentially trade in a range of €7.50 to €8.50 in the short term, driven by the companys efforts to improve its profitability and the overall trend in the personal hygiene products market. A breakout above €8.50 could indicate a more significant upward trend, while a breakdown below €7.01 could signal a more substantial decline. Long-term investors may consider accumulating the stock at current levels, anticipating a potential re-rating as the company demonstrates sustained growth and profitability.

ONTEX Stock Overview

Market Cap in USD 602m
Sub-Industry Personal Care Products
IPO / Inception

ONTEX Stock Ratings

Growth Rating -52.4%
Fundamental 60.8%
Dividend Rating 9.25%
Return 12m vs S&P 500 -38.1%
Analyst Rating -

ONTEX Dividends

Currently no dividends paid

ONTEX Growth Ratios

Growth Correlation 3m -80.1%
Growth Correlation 12m -74.2%
Growth Correlation 5y -32.2%
CAGR 5y -10.12%
CAGR/Max DD 5y -0.18
Sharpe Ratio 12m 0.88
Alpha -34.00
Beta 0.186
Volatility 35.26%
Current Volume 87.1k
Average Volume 20d 115k
Stop Loss 6.3 (-3.2%)
Signal 0.72

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (-85.8m TTM) > 0 and > 6% of Revenue (6% = 165.3m TTM)
FCFTA 0.02 (>2.0%) and ΔFCFTA -1.36pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -0.35% (prev 6.59%; Δ -6.94pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 258.8m > Net Income -85.8m (YES >=105%, WARN >=100%)
Net Debt (600.1m) to EBITDA (260.6m) ratio: 2.30 <= 3.0 (WARN <= 3.5)
Current Ratio 0.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (80.3m) change vs 12m ago -1.00% (target <= -2.0% for YES)
Gross Margin 28.47% (prev 76.85%; Δ -48.38pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 119.2% (prev 118.9%; Δ 0.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.88 (EBITDA TTM 260.6m / Interest Expense TTM 74.1m) >= 6 (WARN >= 3)

Altman Z'' 0.23

(A) -0.00 = (Total Current Assets 766.7m - Total Current Liabilities 776.3m) / Total Assets 2.25b
(B) -0.19 = Retained Earnings (Balance) -422.4m / Total Assets 2.25b
(C) 0.06 = EBIT TTM 139.7m / Avg Total Assets 2.31b
(D) 0.44 = Book Value of Equity 573.4m / Total Liabilities 1.30b
Total Rating: 0.23 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 60.82

1. Piotroski 4.0pt = -1.0
2. FCF Yield 3.99% = 2.00
3. FCF Margin 1.67% = 0.42
4. Debt/Equity 0.77 = 2.21
5. Debt/Ebitda 2.80 = -1.48
6. ROIC - WACC 8.38% = 10.48
7. RoE -9.20% = -1.53
8. Rev. Trend 30.90% = 1.54
9. Rev. CAGR 4.47% = 0.56
10. EPS Trend 4.74% = 0.12
11. EPS CAGR -75.99% = -2.50

What is the price of ONTEX shares?

As of August 31, 2025, the stock is trading at EUR 6.51 with a total of 87,071 shares traded.
Over the past week, the price has changed by -2.25%, over one month by -1.96%, over three months by -16.00% and over the past year by -27.59%.

Is Ontex a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Ontex is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 60.82 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ONTEX is around 5.62 EUR . This means that ONTEX is currently overvalued and has a potential downside of -13.67%.

Is ONTEX a buy, sell or hold?

Ontex has no consensus analysts rating.

What are the forecasts/targets for the ONTEX price?

Issuer Target Up/Down from current
Wallstreet Target Price 7.7 18.3%
Analysts Target Price - -
ValueRay Target Price 6 -7.2%

ONTEX Fundamental Data Overview

Market Cap USD = 601.8m (516.7m EUR * 1.1648 EUR.USD)
Market Cap EUR = 516.7m (516.7m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 96.8m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 72.0
P/E Forward = 12.3457
P/S = 0.2832
P/B = 0.5486
Beta = 0.599
Revenue TTM = 2.75b EUR
EBIT TTM = 139.7m EUR
EBITDA TTM = 260.6m EUR
Long Term Debt = 522.4m EUR (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 208.2m EUR (from shortTermDebt, last quarter)
Debt = 730.6m EUR (Calculated: Short Term 208.2m + Long Term 522.4m)
Net Debt = 600.1m EUR (from netDebt column, last quarter)
Enterprise Value = 1.15b EUR (516.7m + Debt 730.6m - CCE 96.8m)
Interest Coverage Ratio = 1.88 (Ebit TTM 139.7m / Interest Expense TTM 74.1m)
FCF Yield = 3.99% (FCF TTM 45.9m / Enterprise Value 1.15b)
FCF Margin = 1.67% (FCF TTM 45.9m / Revenue TTM 2.75b)
Net Margin = -3.11% (Net Income TTM -85.8m / Revenue TTM 2.75b)
Gross Margin = 28.47% ((Revenue TTM 2.75b - Cost of Revenue TTM 1.97b) / Revenue TTM)
Tobins Q-Ratio = 2.01 (Enterprise Value 1.15b / Book Value Of Equity 573.4m)
Interest Expense / Debt = 3.59% (Interest Expense 26.2m / Debt 730.6m)
Taxrate = 13.99% (from yearly Income Tax Expense: 3.40m / 24.3m)
NOPAT = 120.1m (EBIT 139.7m * (1 - 13.99%))
Current Ratio = 0.99 (Total Current Assets 766.7m / Total Current Liabilities 776.3m)
Debt / Equity = 0.77 (Debt 730.6m / last Quarter total Stockholder Equity 950.5m)
Debt / EBITDA = 2.80 (Net Debt 600.1m / EBITDA 260.6m)
Debt / FCF = 15.90 (Debt 730.6m / FCF TTM 45.9m)
Total Stockholder Equity = 932.2m (last 4 quarters mean)
RoA = -3.81% (Net Income -85.8m, Total Assets 2.25b )
RoE = -9.20% (Net Income TTM -85.8m / Total Stockholder Equity 932.2m)
RoCE = 9.60% (Ebit 139.7m / (Equity 932.2m + L.T.Debt 522.4m))
RoIC = 12.97% (NOPAT 120.1m / Invested Capital 926.4m)
WACC = 4.58% (E(516.7m)/V(1.25b) * Re(6.70%)) + (D(730.6m)/V(1.25b) * Rd(3.59%) * (1-Tc(0.14)))
Shares Correlation 5-Years: -10.0 | Cagr: -0.19%
Discount Rate = 6.70% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈59.9m ; Y1≈39.3m ; Y5≈18.0m
Fair Price DCF = 4.43 (DCF Value 353.4m / Shares Outstanding 79.7m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 30.90 | Revenue CAGR: 4.47%
Rev Growth-of-Growth: -13.95
EPS Correlation: 4.74 | EPS CAGR: -75.99%
EPS Growth-of-Growth: -274.7

Additional Sources for ONTEX Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle